Researcher develops acoustic resonant sensor that can test bodily fluids for variety of diseases

MU researcher developing a sensor to detect diseases, such as breast cancer, in bodily fluids

What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.

"Many disease-related substances in liquids are not easily tracked," said Jae Kwon, assistant professor of electrical and computer engineering at MU. "In a liquid environment, most sensors experience a significant loss of signal quality, but by using highly sensitive, low-signal-loss acoustic resonant sensors in a liquid, these substances can be effectively and quickly detected - a brand-new concept that will result in a noninvasive approach for breast cancer detection."

Kwon's real-time, special acoustic resonant sensor uses micro/nanoelectromechanical systems (M/NEMS), which are tiny devices smaller than the diameter of a human hair, to directly detect diseases in body fluids. The sensor doesn't require bulky data reading or analyzing equipment and can be integrated with equally small circuits, creating the potential for small stand-alone disease-screening systems. Kwon's sensor also produces rapid, almost immediate results that could reduce patient anxiety often felt after waiting for other detection methods, such as biopsies, which can take several days or weeks before results are known.

"Our ultimate goal is to produce a device that will simply and quickly diagnose multiple specific diseases, and eventually be used to create 'point of care' systems, which are services provided to patients at their bedsides," Kwon said. "The sensor has strong commercial potential to be manifested as simple home kits for easy, rapid and accurate diagnosis of various diseases, such as breast cancer and prostate cancer."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative urine test could improve pancreatic cancer survival rates